Walgreens Boots Alliance price target raised to $27 from $25 at Truist

Truist raised the firm’s price target on Walgreens Boots Alliance to $27 from $25 and keeps a Hold rating on the shares. The company’s Q4 results reflected its continued challenges while its FY24 guidance came in below the firm’s view reflects a handful of headwinds and assumes solid underlying growth, the analyst tells investors in a research note. Truist adds however that Walgreens Boot is taking steps to improve free cash flows, right size the cost structure, and drive better profitability in the U.S. Healthcare segment.